Spero Therapeutics Inc
NASDAQ:SPRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
US |
|
M
|
Metalore Resources Ltd
OTC:MTLRF
|
CA |
|
China Resources Beer Holdings Co Ltd
F:CHK0
|
HK |
|
OneWater Marine Inc
NASDAQ:ONEW
|
US |
|
D2L Inc
F:NE5
|
CA |
|
D
|
Deutsche Post AG
XMUN:DHL
|
DE |
|
V
|
Vinci SA
XHAM:SQU
|
FR |
|
Corporate Travel Management Ltd
ASX:CTD
|
AU |
|
B
|
Bank of China Ltd
OTC:BACHF
|
CN |
|
A
|
Autodesk Inc
F:AUD
|
US |
Intrinsic Value
Is SPRO undervalued or overvalued?
See the intrinsic value estimate for
Spero Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Spero Therapeutics Does
Spero Therapeutics is a biotechnology company that develops medicines for hard-to-treat bacterial infections, with a focus on infections caused by drug-resistant Gram-negative bacteria. Its work centers on antibiotic candidates designed to be taken by mouth or given in other convenient ways, so they can treat serious infections that often require hospital care.
- Headquarters
- United States of America US
- Employees
- 25
- IPO date
- Nov 2, 2017
Revenue & Expenses Breakdown
Spero Therapeutics Inc
Earnings Waterfall
Spero Therapeutics Inc
The intrinsic value for
Spero Therapeutics Inc (SPRO) under the Base Case is hidden USD.
Compared with the current market price of 1.04 USD, the stock appears hidden.